scispace - formally typeset
Journal ArticleDOI

Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus

TLDR
Overall, patients with BE and LGD have a low annual incidence of EAC, similar to nondysplastic BE, and there is significant interobserver variation in diagnosis, even among expert pathologists.
About
This article is published in Gastroenterology.The article was published on 2011-10-01. It has received 243 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia: A Randomized Clinical Trial

TL;DR: Radiofrequency ablation resulted in a reduced risk of neoplastic progression over 3 years of follow-up and the data and safety monitoring board recommended early termination of the trial due to superiority of ablation for the primary outcome and the potential for patient safety issues if the trial continued.
Journal ArticleDOI

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

Cathy Bennett, +92 more
- 01 Aug 2012 - 
TL;DR: An international, multidisciplinary, systematic, evidence-based review of different management strategies for patients with Barrett's esophagus and dysplasia or early-stage EA and developed a data-sifting platform and used the Delphi process to create evidence- based consensus statements.
Journal ArticleDOI

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel

TL;DR: Confirmed LGD in BO has a markedly increased risk of malignant progression, however, the vast majority of patients with community LGD will be downstaged after expert review and have a low progression risk.
Related Papers (5)